OpenAI Backs Isara, Blossom Health Secures $20M, and Eli Lilly's $2.75B Deal - Life AI Weekly #61
April 01, 2026 -
Life AI Weekly
Hi there,
Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in healthcare and life sciences AI. This week, we're spotlighting significant investments and partnerships that are shaping the future of AI in these sectors. OpenAI has made a strategic investment in Isara, a company developing software for AI agent collaboration, with a focus on industries like finance and biotech. Meanwhile, Blossom Health has raised $20 million to enhance its AI-powered psychiatry platform, aiming to revolutionize psychiatric care delivery across the United States.
In other news, Insilico Medicine has entered a substantial $2.75 billion drug development deal with Eli Lilly, marking a significant milestone in AI-driven drug discovery. Qualified Health has also secured $125 million to boost its AI platform for health systems, while Stratum Biosciences is advancing AI dermatology research with a $2 million seed funding. These stories, along with other notable developments, highlight the transformative impact of AI in healthcare and life sciences.
Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in healthcare and life sciences AI. This week, we're spotlighting significant investments and partnerships that are shaping the future of AI in these sectors. OpenAI has made a strategic investment in Isara, a company developing software for AI agent collaboration, with a focus on industries like finance and biotech. Meanwhile, Blossom Health has raised $20 million to enhance its AI-powered psychiatry platform, aiming to revolutionize psychiatric care delivery across the United States.
In other news, Insilico Medicine has entered a substantial $2.75 billion drug development deal with Eli Lilly, marking a significant milestone in AI-driven drug discovery. Qualified Health has also secured $125 million to boost its AI platform for health systems, while Stratum Biosciences is advancing AI dermatology research with a $2 million seed funding. These stories, along with other notable developments, highlight the transformative impact of AI in healthcare and life sciences.
OpenAI Invests in Isara for AI Coordination Software
OpenAI has invested in Isara, a startup focused on developing software for AI agent collaboration. The company raised $94 million to target industries like finance and biotech. Read more
Blossom Health Raises $20 Million for AI Psychiatry Platform
Blossom Health has secured $20 million in funding to expand its AI-powered psychiatry platform, aiming to improve psychiatric care in the U.S. by enhancing clinical decision-making and reducing administrative tasks. Read more
Insilico Medicine and Eli Lilly's $2.75 Billion Drug Deal
Insilico Medicine has entered a global licensing and research agreement with Eli Lilly, potentially worth up to $2.75 billion, to develop preclinical oral drug candidates targeting specific diseases. Read more
Qualified Health Raises $125 Million for AI in Healthcare
Qualified Health has secured $125 million in a Series B funding round led by New Enterprise Associates to enhance its AI platform for health systems. The company, founded in 2023, is now valued between $500 million and $1 billion. Read more
Stratum Biosciences Raises $2M for AI Dermatology Platform
Stratum Biosciences has secured $2M in seed funding to advance its AI-driven skin biology discovery platform, aimed at enhancing dermatology research. Read more
Collectly Acquires Pledge Health for AI Automation
On March 26, 2026, Collectly announced its acquisition of Pledge Health to enhance AI-driven automation in patient financial workflows, aiming to streamline operations for healthcare facilities. Read more
eMed Raises $200 Million, Valued Over $2 Billion
Telehealth company eMed, supported by Tom Brady, has secured $200 million in funding, increasing its valuation to over $2 billion. The company aims to reduce healthcare costs using its AI platform. Read more
ProviderTrust Launches AI Governance Program
ProviderTrust has introduced its AI Trust & Integrity Program and AI Integrity Council, establishing the first formal AI governance body in the healthcare eligibility data sector to ensure responsible AI use. Read more
n6 Launches icon16™ for NGS Workflows
The n6 company has introduced icon16™, a new format of its AutoNorm™ technology, aimed at improving data quality and efficiency in lower-throughput next-generation sequencing workflows. Read more
Mantis Biotech Develops Digital Twins for Medicine
Mantis Biotech is creating digital twins of humans to address data scarcity in medicine, using synthesized data for predictive models. The company has secured $7.4 million in seed funding to advance its technology. Read more
BullFrog AI Partners with Global Pharma for MDD Drug Development
BullFrog AI Holdings, Inc. has signed a commercial agreement with a top global pharmaceutical company to use its bfLEAP® platform for drug target identification in major depressive disorder. Read more
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
03/28
Brook.ai Wins Dual Pinnacle Awards for AI-Powered Remote Care Platform
03/28
Children’s National Hospital Launches Division of AI Research for Pediatric Medicine
03/27
Carrot Launches AI System to Detect Fraud in Global Fertility Care
03/20
Viva Biotech and NVIDIA Advance AI-Driven Mini-Binder Design for Drug Discovery
03/20
Jennifer Yoo Rejoins Latham & Watkins as Healthcare Partner in Los Angeles
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
